CURREN REPORT

Company

Estrella Immunopharma, Inc.

Filed

January 13, 2026

Period of Report

January 7, 2026

Accession Number

0001213900-26-003998

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →